iPharma | MOTS-c 30mg - 1.8ml | Compound Peptide Pen
Advanced Mitochondrial-Derived Peptide Research Compound
iPharma MOTS-c 30mg is an investigational mitochondrial-derived peptide research compound studied for its role in cellular energy regulation, metabolic signalling, and mitochondrial communication pathways within controlled laboratory environments.
MOTS-c is widely referenced in scientific research exploring glucose metabolism, insulin sensitivity pathways, metabolic flexibility, and cellular stress response mechanisms, particularly in studies focused on mitochondrial function and energy homeostasis.
Developed as a 30mg (1.8ml) compound peptide pen, this formulation is designed for laboratory preparation and controlled research applications where mitochondrial biology and metabolic pathway investigation are of scientific interest.
iPharma MOTS-c 30mg Compound Peptide Pen (1.8ml)
• Mitochondrial-derived peptide research compound (MOTS-c)
• Investigated in cellular energy and metabolic regulation studies
• Studied in glucose metabolism and insulin signalling pathways
• Of interest in mitochondrial function and cellular stress response research
• Explored in metabolic flexibility and energy homeostasis models
• 30mg (1.8ml) pen format designed for laboratory preparation use
• High-purity investigational formulation from iPharma
• Strictly intended for laboratory research use only
⚖️ DISCLAIMER
This product is intended strictly for laboratory research purposes only. It is not a medicine and has not been evaluated or approved by the South African Health Products Regulatory Authority (SAHPHRA) for human or animal use.
This product is supplied strictly for laboratory research purposes only and is not intended for human consumption.
Products sold on this website are not intended to diagnose, treat, cure, or prevent any disease.
